多发性硬化的T1/T2比值脑微结构损伤多中心研究
该多中心研究纳入918例多发性硬化患者与272名健康对照,基于标准化3D T1和T2加权MRI计算T1/T2比值。结果显示患者病灶、正常表现白质及皮层灰质比值降低,丘脑与深部灰质比值升高。不同MS表型、起病年龄及残疾、认知表现与比值存在相关性。
要点
- T1/T2比值可反映MS不同脑区组织完整性差异
- 病灶、正常表现白质、皮层灰质比值降低提示微结构损伤
- 丘脑与深部灰质比值升高需结合临床解读
核心结论
- T1/T2比值图可提供MS谱系中组织完整性与临床结局的互补、分区特异性信息。
研究设计与样本
- 意大利神经影像倡议多中心研究,纳入918例多发性硬化患者和272名健康对照。
- 采用标准化3D T1和T2加权MRI,T2序列因中心不同可为3D或2D双回波序列。
- 使用标准化流程计算T1/T2比值,并以健康对照拟合线性混合效应模型得到MS患者各脑区z分数。
关键影像表现/征象
- 与健康对照相比,MS患者病灶、正常表现白质和皮层灰质T1/T2比值降低。
- MS患者丘脑和深部灰质T1/T2比值较健康对照升高。
- 继发进展型与复发缓解型MS的比值差异比临床孤立综合征和原发进展型更明显。
- 儿童起病患者正常表现白质与皮层灰质比值低于成人起病和晚起病患者。
- 成人起病和晚起病患者深部灰质比值高于其他起病年龄组。
诊断标准与关键数值
- 病灶、正常表现白质、皮层灰质比值降低:与健康对照比较FDR校正p值均<.001。
- 丘脑与深部灰质比值升高:与健康对照比较FDR校正p值均≤.01。
- 较高残疾与病灶、正常表现白质、皮层灰质比值降低相关(p均≤.05),与丘脑比值升高相关(p=.006)。
- 较长病程与病灶比值降低(p=.02)、正常表现白质比值降低(p=.007)及深部灰质比值升高(p=.002)相关。
- 较差认知表现与皮层比值降低(p=.01)及丘脑、深部灰质比值升高相关(p均≤.004)。
临床应用与阅片要点
- 阅片时可关注MS患者病灶及正常表现白质、皮层灰质T1/T2比值降低。
- 丘脑与深部灰质比值升高在MS中可能提示不同病理过程,需避免简单解读为组织正常。
- 报告时可结合病程、起病年龄和残疾程度理解各脑区比值变化方向。
局限性
- 原文未明确说明具体中心数量及不同T2序列类型对结果的影响。
- T1/T2比值反映髓鞘的特异性在多发性硬化中存在争议,需结合其他序列综合判断。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND AND PURPOSE: The T1-weighted/T2-weighted ratio, a proposed surrogate measure of myelin integrity/damage, has debated specificity in multiple sclerosis. We investigated compartment-specific T1-weighted/T2-weighted alterations across multiple sclerosis phenotypes and age at onset, and their associations with disability and cognition.
MATERIALS AND METHODS: In this multicenter study, 918 multiple sclerosis and 272 healthy controls from an Italian neuroimaging initiative underwent standardized 3D T1- and T2-weighted MRI (3D or 2D dual-echo sequences depending on site), together with clinical and cognitive assessments. T1-weighted/T2-weighted ratios were computed using a standardized pipeline and multiple sclerosis z-scores were derived across brain regions using linear mixed-effects models fitted on healthy controls. Associations with disease duration, disability, and Symbol Digit Modalities Test were analyzed.
RESULTS: Compared with healthy controls, patients showed lower T1-weighted/T2-weighted ratios in lesions, normal-appearing white matter, and cortical grey matter (all FDR-adjusted p-values<.001), and higher ratios in the thalamus and deep grey matter (all FDR-adjusted p-values≤.01). Differences were more pronounced in secondary progressive and relapsing-remitting multiple sclerosis (all FDR-adjusted p-values<.001) than clinically isolated syndrome and primary progressive. Pediatric-onset patients showed lower normal-appearing white matter and cortical grey matter ratios (all FDR-adjusted p-values≤.02) than adult- and late-onset patients, which conversely showed higher deep grey matter ratios compared to the other groups (all FDR-adjusted p-values≤.01). Higher disability was associated to lower lesion, normal-appearing white matter, cortical grey matter ratios (all p≤.05) and higher thalamic ratios (p=.006). Longer disease duration correlated with lower lesion (p=.02), normal-appearing white matter ratios (p=.007) and higher deep grey matter ratios (p=.002). Worse cognitive performance was associated with lower cortical (p=.01), and higher thalamic and deep grey matter ratios (all p≤.004).
CONCLUSIONS: T1-weighted/T2-weighted mapping can provide complementary, compartment-specific information on tissue integrity and clinical outcomes across the MS spectrum.
引用
- Storelli, Preziosa, Tedone, et al. T1W/T2W Ratio to Assess Brain Microstructural Damage in Multiple Sclerosis: A Multicenter Study. AJNR Am J Neuroradiol. 2026. PMID: 42336673. doi:10.3174/ajnr.A9488
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。